AngioDynamics, Inc. (NASDAQ:ANGO) medical instruments manufacturer and supplier will be discussing 4Q20 financial results with the investment community.on 16th July 2020 at 8:00 AM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.angiodynamics.com
Investors who wish to participate in the conference call may call, 1-877-407-0784 U.S. or +1-201-689-8560 Outside U.S., and the passcode is 13705722.
The recording of the call will be available in the company website, the dial-in number(s) are 1-844-512-2921 Toll Free, (United States) or +1-412-317-6671 Toll Number, and the passcode is 13705722.
Earnings Expectation
AngioDynamics, Inc. medical instruments manufacturer and supplier, is reporting fourth quarter earnings results on Thursday 16th July 2020, before market open. The consensus estimates from Thomson Reuters are loss of $ 0.06 per share. For the full year, analysts predict revenues of $ 268.43 million, while looking forward to income of $ 0.09 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 280.00 million ~ $ 286.00 million, where as bottomline are predicted in a range of $ 0.10 ~ $ 0.15 per share
Click Here For More Historical Outlooks Of AngioDynamics, Inc.
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors.
